Analyzing Mitesco (OTCMKTS:MITI) & Inspire Medical Systems (NYSE:INSP)

Mitesco (OTCMKTS:MITI) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation.

Volatility and Risk

Mitesco has a beta of 2.17, indicating that its stock price is 117% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.

Profitability

This table compares Mitesco and Inspire Medical Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mitesco	1,639.45%	N/A	-744.83%
Inspire Medical Systems	6.17%	10.38%	8.93%

Valuation & Earnings

This table compares Mitesco and Inspire Medical Systems”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mitesco	$40,000.00	109.42	-$2.51 million	N/A	N/A
Inspire Medical Systems	$802.80 million	2.87	$53.51 million	$1.73	45.10

Inspire Medical Systems has higher revenue and earnings than Mitesco.

Institutional and Insider Ownership

0.0% of Mitesco shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.9% of Mitesco shares are owned by company insiders. Comparatively, 4.1% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Mitesco and Inspire Medical Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mitesco	0	0	0	0	0.00
Inspire Medical Systems	1	7	7	0	2.40

Inspire Medical Systems has a consensus target price of $148.00, indicating a potential upside of 89.67%. Given Inspire Medical Systems’ stronger consensus rating and higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than Mitesco.

Summary

Inspire Medical Systems beats Mitesco on 8 of the 12 factors compared between the two stocks.

About Mitesco

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.